Tatva Chintan Pharma IPO Allotment Status Online

  

Tatva Chintan Pharma Chem Ltd IPO

Tatva Chintan Pharma Chem Ltd IPO

Tatva Chintan Pharma IPO Schedule

• Bid/Offer Opens On: Jul 16, 2021
• Bid/Offer Closes On: Jul 20, 2021
• Finalization of Basis of Allotment: Jul 26, 2021
• Initiation of refunds: Jul 27, 2021
• Credit of Equity Shares: Jul 28, 2021
• Listing Date: Jul 29, 2021

Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.

The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.

Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.

Competitive strengths

• Leading manufacturer of structure directing agents and phase transfer catalyst.
• Diversified product portfolio.
• Global market presence with customer base across industries.
• Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
• Experienced promoters and managers team.
• Strong financial performance track record.

Company Promoters:

Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani are the company promoters.

Company Financials:

Summary of financial Information (Restated Consolidated)

Particulars	For the year/period ended (₹ in million)
	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	3,148.03	2,489.38	1,875.08
Total Revenue	3,062.92	2,646.22	2,068.01
Profit After Tax	522.62	377.89	205.43

Objects of the Issue:

• Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
• Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
• To meet general corporate purposes.

Particulars

For the year/period ended (₹ in million)
31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	3,148.03	2,489.38	1,875.08
Total Revenue	3,062.92	2,646.22	2,068.01
Profit After Tax	522.62	377.89	205.43

Objects of the Issue:

• Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
• Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
• To meet general corporate purposes.